24/7 Helpline 800.272.3900
Donate

Dominantly Inherited Alzheimer Network trial completes participant enrollment for two drugs in a phase II/III study of amyloid therapies

Dominantly Inherited Alzheimer Network trial completes participant enrollment for two drugs in a pha
Dominantly Inherited Alzheimer Network trial completes participant enrollment for two drugs in a pha
Share or Print this page
December 7, 2015
Email: media@alz.org
Media Line: 312.335.4078
Share or Print this page

Dominantly Inherited Alzheimer Network trial completes participant enrollment for two drugs in a phase II/III study of amyloid therapies

Alzheimer's Association

The Alzheimer's Association is the world's leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more information, visit www.alz.org.

Keep Up With Alzheimer’s News and Events